ORAL VERSUS IM ADMINISTRATION OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PRETREATED PATIENTS WITH ADVANCED BREAST-CANCER

被引：0
|
作者：
BEEX, L
BURGHOUTS, J
VANTURNHOUT, J
BREED, W
HILLEN, H
HOLDRINET, A
BOETIUS, G
HOOGENDOORN, G
DOESBURG, W
VERHULST, M
MEULENBERG, P
机构：
[1] ST RADBOUD HOSP, DEPT EXPTL & CHEM ENDOCRINOL, 6525 GA NIJMEGEN, NETHERLANDS
[2] CATHOLIC UNIV NIJMEGEN, DEPT STAT CONSULTAT, NIJMEGEN, NETHERLANDS
[3] GROOT ZIEKENGASTHUIS, DEPT MED, SHERTOGENBOSCH, NETHERLANDS
[4] ST CANISIUS WILHELMINA HOSP, NIJMEGEN, NETHERLANDS
[5] ST CATHARINA HOSP, EINDHOVEN, NETHERLANDS
[6] ST IGNATIUS HOSP, BREDA, NETHERLANDS
[7] DIACONESSEN HOSP, BREDA, NETHERLANDS
[8] ST GEERTRUIDEN HOSP, DEVENTER, NETHERLANDS
来源：
CANCER TREATMENT REPORTS | 1987年 / 71卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1151 / 1156
页数：6
相关论文
共 50 条
  • [31] CHEMOTHERAPY WITH OR WITHOUT HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ESTROGEN-RECEPTOR-NEGATIVE ADVANCED BREAST-CANCER
    GUNDERSEN, S
    KVINNSLAND, S
    KLEPP, O
    LUND, E
    HANNISDAL, E
    HOST, H
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) : 390 - 394
  • [32] HIGH-DOSE MEDROXYPROGESTERONE ACETATE PLUS MITOMYCIN-C OR VINDESINE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, HC
    FALKSON, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04): : 431 - 434
  • [33] SEQUENTIAL COMBINATION OF TAMOXIFEN AND HIGH-DOSE MEDROXYPROGESTERONE ACETATE - THERAPEUTIC AND ENDOCRINE EFFECTS IN POSTMENOPAUSAL ADVANCED BREAST-CANCER PATIENTS
    GASPARINI, G
    CANOBBIO, L
    GALLIGIONI, E
    FASSIO, T
    BREMA, F
    CRIVELLARI, D
    VILLALTA, D
    DIFRONZO, G
    TALAMINI, R
    MONFARDINI, S
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (10): : 1451 - 1459
  • [34] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER RESISTANT TO ENDOCRINE AND CYTOTOXIC THERAPY
    DELENA, M
    BRAMBILLA, C
    VALAGUSSA, P
    BONADONNA, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 2 (03) : 175 - 180
  • [35] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH ADVANCED PROSTATIC-CANCER
    SULMONI, M
    PFENNINGER, R
    MULLER, J
    BANDHAUER, K
    AKTUELLE UROLOGIE, 1993, 24 (06) : 334 - 337
  • [36] ORAL HIGH-DOSE OF MEDROXYPROGESTERONE ACETATE (MPA) IN THE TREATMENT OF ADVANCED BREAST AND ENDOMETRIAL CARCINOMA
    BERNARDOSTRADA, MR
    IMPARATO, E
    ASPESI, G
    PAVESI, L
    DELLACUNA, GR
    MINERVA MEDICA, 1980, 71 (44) : 3241 - 3246
  • [37] MEDROXYPROGESTERONE ACETATE VERSUS TAMOXIFEN IN THE THERAPY OF ADVANCED BREAST-CANCER
    LORENZ, I
    MECHL, Z
    NEOPLASMA, 1985, 32 (01) : 119 - 124
  • [38] MEDROXYPROGESTERONE ACETATE (MPA) VERSUS TAMOXIFEN IN ADVANCED BREAST-CANCER
    MORANDI, P
    FORNASIERO, A
    DANIELE, O
    AVERSA, SML
    GHIOTTO, C
    FOSSER, VP
    FIORENTINO, MV
    TUMORI, 1986, 72 (06) : 719 - 719
  • [39] ORAL VERSUS INTRAMUSCULAR HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) IN ADVANCED BREAST-CANCER - A RANDOMIZED STUDY OF THE BELGIAN-SOCIETY-OF-MEDICAL-ONCOLOGY
    PARIDAENS, R
    BECQUART, D
    MICHEL, J
    VANDERLINDEN, B
    LONGUEVILLE, J
    MAJOIS, F
    BEAUDUIN, M
    FOCAN, C
    WILDIERS, J
    BERNHEIM, J
    LOBELLE, JP
    ARRIGO, C
    SYLVESTER, RJ
    HEUSON, JC
    ANTICANCER RESEARCH, 1986, 6 (05) : 1089 - 1094
  • [40] TAMOXIFEN VERSUS HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE AS INITIAL ENDOCRINE THERAPY FOR PATIENTS WITH METASTATIC BREAST-CANCER - A PIEDMONT-ONCOLOGY-ASSOCIATION STUDY
    MUSS, HB
    CASE, LD
    ATKINS, JN
    BEARDEN, JD
    COOPER, MR
    CRUZ, JM
    JACKSON, DV
    OROURKE, MA
    PAVY, MD
    POWELL, BL
    RICHARDS, F
    SPURR, CL
    EAGLE, K
    WHITE, DR
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (08) : 1630 - 1638
12345